Keyphrases
Abciximab
40%
Acute Myocardial Infarction
100%
Acute ST-segment Elevation Myocardial Infarction
80%
Adjunctive Use
20%
Confidence Interval
40%
Conservative Approach
20%
Conservative Treatment
20%
Coronary Stenting
40%
Current Guidelines
20%
Infarct Size
100%
Invasive Strategy
40%
Invasive Treatment
20%
Left Ventricular Function
60%
Mechanical Reperfusion
100%
Persistent Symptoms
40%
Primary Percutaneous Coronary Intervention
20%
Random Assignment
20%
Randomized Controlled Trial
100%
Relative Risk
20%
Reperfusion Therapy
20%
Single-photon Emission Computed Tomography (SPECT)
20%
Symptom Onset
100%
Technetium Tc 99m Sestamibi
20%
Treatment Strategy
40%
Medicine and Dentistry
Abciximab
40%
Acute Heart Infarction
100%
Apoplexy
40%
Computed Tomography Studies
20%
Conservative Treatment
20%
Coronary Stenting
40%
Infarction
100%
Invasive Procedure
20%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
20%
Primary Percutaneous Coronary Intervention
20%
Randomized Controlled Trial
100%
Single-Photon Emission Computed Tomography
20%
ST Segment Elevation Myocardial Infarction
80%
Pharmacology, Toxicology and Pharmaceutical Science
Abciximab
40%
Acute Heart Infarction
100%
Cerebrovascular Accident
40%
Computed Tomography Studies
20%
Infarction
100%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
20%
Randomized Controlled Trial
100%
ST Segment Elevation Myocardial Infarction
80%